LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

Kodu・Aktsiate loetelu・CorMedix Inc

CorMedix Inc

Suletud

SektorTervishoid

11.69 5.41

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

11.06

Max

11.75

Põhinäitajad
By Trading Economics
Sissetulek	40B 40B
Müük	655K 40M
P/E Sektori keskmine	16.645 35.293
Aktsiakasum	0.28
Kasumimarginaal	101,797.944
Töötajad	64
EBITDA	-297K 21M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+76.88% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	29. okt 2025

Turustatistika
By TradingEconomics
Turukapital	45M 966M
Eelmine avamishind	6.28
Eelmine sulgemishind	11.69

Uudiste sentiment

By Acuity

58%

42%

138 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

9.2 / N/A Toetus ja vastupanu

CorMedix Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

18. sept 2025, 23:56 UTC

Kuumad aktsiad

Stocks to Watch: FedEx, 22nd Century, Scholastic

18. sept 2025, 22:01 UTC

Suurimad hinnamuutused turgudel

22nd Century Group Shares Gain on Debt Repayment, New Capital

18. sept 2025, 20:51 UTC

Omandamised, ülevõtmised, äriostud

UPS Terminates Plan to Buy Estafeta

18. sept 2025, 20:31 UTC

Tulu

FedEx 1Q Profit, Sales Rise on Improvement in U.S. Shipping -- Update

18. sept 2025, 20:26 UTC

Tulu

FedEx 1Q Profit, Sales Rise on Improvement in U.S. Shipping

18. sept 2025, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18. sept 2025, 23:43 UTC

Market Talk

Nikkei May Rise on U.S. Stock Gains, Weaker Yen -- Market Talk

18. sept 2025, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

18. sept 2025, 23:40 UTC

Market Talk

Gold Edges Lower Amid Cautious Mood -- Market Talk

18. sept 2025, 23:31 UTC

Market Talk

FedEx Says U.S. Demand Is Resilient -- Market Talk

18. sept 2025, 22:03 UTC

Tulu

FedEx Expects Trade Environment to Create $1B Headwind in 2026, CFO Says

18. sept 2025, 22:01 UTC

Tulu

FedEx CFO: Asia-to-U.S. Declines Drove $150M International Export Headwind

18. sept 2025, 21:56 UTC

Tulu

Lennar Missed Revenue Estimates. The Stock Is Down. -- Barrons.com

18. sept 2025, 21:54 UTC

Tulu

FedEx Focused on Demand From Southeast Asia, Europe Amid China Shipping Slowdown, Customer Chief Says

18. sept 2025, 21:48 UTC

Tulu

FedEx International Export Volumes Declined, Especially on China-to-U.S. Lane, Exec Says

18. sept 2025, 21:47 UTC

Tulu

FedEx Had 5% Increase in U.S. Domestic Average Daily Package Volume in 1Q, Customer Chief Says

18. sept 2025, 21:17 UTC

Tulu

FedEx Profit, Sales Rise on Improvement in U.S. Shipping -- 2nd Update

18. sept 2025, 21:07 UTC

Tulu

FedEx Earnings Were a Relief. The Stock Is Up. -- Barrons.com

18. sept 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18. sept 2025, 20:50 UTC

Market Talk

Tulu

Financial Services Roundup: Market Talk

18. sept 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

18. sept 2025, 20:22 UTC

Omandamised, ülevõtmised, äriostud

UPS Cites Inability of All Closing Conditions to Be Satisfied

18. sept 2025, 20:22 UTC

Omandamised, ülevõtmised, äriostud

United Parcel Service Terminates Plan to Buy Estafeta

18. sept 2025, 20:20 UTC

Omandamised, ülevõtmised, äriostud

Here's How Much the U.S. Has Made on Its Intel Stock Purchase -- Barrons.com

18. sept 2025, 20:18 UTC

Tulu

Nucor Stock Falls After Earnings. Why Its Guidance Was Far Off Rival Steel Dynamics. -- Barrons.com

18. sept 2025, 20:18 UTC

Tulu

Bullish Crushes Earnings. The Crypto Stock Pops. -- Barrons.com

18. sept 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

18. sept 2025, 20:07 UTC

Tulu

FedEx Earnings Were a Relief. The Stock Is Up. -- Barrons.com

18. sept 2025, 20:03 UTC

Tulu

FedEx 1Q FedEx Freight Segment Revenue $2.26B >FDX

Võrdlus sarnastega

Hinnamuutus

CorMedix Inc Prognoos

Hinnasiht

By TipRanks

76.88% tõus

12 kuu keskmine prognoos

Keskmine 20.5 USD 76.88%

Kõrge 23 USD

Madal 17 USD

Põhineb 7 Wall Streeti analüütiku instrumendi CorMedix Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

7 ratings

Osta

Hoia

Müü

Põhineb 7 analüütiku instrumendi CorMedix Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

9.2 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

138 / 371 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.